Illumina and Siemens to Co-Develop MDx Tests on the MiSeq
November 02, 2011
Illumina and Siemens to Co-Develop MDx Tests on the MiSeq
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News - Illumina Focuses on Reproductive Health; May Modify MiSeq/HiSeq for Different Clinical Needs
January 30, 2013 / Clinical Sequencing News - MiSeq Customers, WGS Service, and T21 Test Developers Drive Illumina's Clinical Business
October 24, 2012 / Clinical Sequencing News - Illumina in Discussions with 100 Potential Clinical Customers for MiSeq, Plans Cancer Diagnostics
April 25, 2012 / Clinical Sequencing News - Illumina Sees Growing Commercial Customer Base; Doubled Clinical HiSeq Placements in 2011
February 8, 2012 / Clinical Sequencing News